Codexis Inc - Company Profile
Powered by 
All the sales intelligence you need on Codexis Inc in one solution.
- Save hours of research time with a comprehensive
Sales Intelligence Solution.
- Understand how Codexis Inc fits into your total
addressable market and Ideal Customer Profile.
- Gain competitive edge with triggers that tell you
when and how to engage with Codexis Inc.
Get in touch about GlobalData Company reports
Contact the team or request a demo to find out how our data can drive your business forward
Codexis Inc (Codexis) is a protein engineering company that discovers, develops, and markets synthetic proteins. It sells biocatalysts for the commercial manufacture of pharmaceuticals and industrial enzymes and fine chemicals, and enzymes as biotherapeutics and for use in molecular diagnostics. The company identifies, optimizes, and produces enzymes by using CodeEvolver, its proprietary protein engineering technology platform, which introduces mutation into genes to transform the enzymes that they produce. It also offers a range of biocatalyst solutions including robotic high-throughput screening, organic chemistry and process development, and genomic sequencing. The company serves pharmaceutical, food manufacturing, agricultural feed, consumer care, and chemical companies. Codexis is headquartered in Redwood City, California, the US.
Headquarters
United States of America
Address
200 Penobscot Dr, Redwood City, California, 94063-4718
Website
www.codexis.com
Telephone
1 650 4218100
No of Employees
146
Industry
Pharmaceuticals and Healthcare
Ticker Symbol & Exchange
CDXS (NASD)
Revenue (2025)
$70.4M
18.6%
(2025 vs 2024)
EPS
XYZ
Net Income (2025)
XYZ
32.6%
(2025 vs 2024)
Market Cap*
$217.2M
Net Profit Margin (2025)
XYZ
43.2%
(2025 vs 2024)
* As of and is in US$
Codexis Inc premium industry data and analytics
Products and Services
| Products | Services | Brands |
|---|---|---|
| Active Pharmaceutical Ingredients | Biocatalysis Solutions | Codex |
| Codex Screening Panels and Kits | Screening | Codexis |
| Enzyme Platforms | Enzyme Optimization Services | Unlock the Power of Proteins |
| XYZ | XYZ | |
| XYZ | XYZ | |
| XYZ | XYZ |
History
History section provides information on new products, mergers, acquisitions, expansions, approvals, and many more key events.
| Year | Event | Description |
|---|---|---|
| 2026 | Contracts/Agreements | In March, the company signed an agreement with an innovator pharmaceutical company to develop 50 grams of small interfering RNA. |
| 2026 | Contracts/Agreements | In January, the company signed an agreement under which Axolabs will evaluate its ECO Synthesis Manufacturing Platform. |
| 2025 | Contracts/Agreements | In November, the company signed a lease agreement for a 34,000-square-foot GMP manufacturing facility in Hayward, California, the US. |
Competitor Comparison
| Key Parameters | Codexis Inc | BASF SE | AstraZeneca Plc | Novartis AG | Bayer AG |
|---|---|---|---|---|---|
| Headquarters | United States of America | Germany | United Kingdom | Switzerland | Germany |
| City | Redwood City | Ludwigshafen | Cambridge | Basel | Leverkusen |
| State/Province | California | Rheinland-Pfalz | Cambridgeshire | Basel-Stadt | Nordrhein-Westfalen |
| No. of Employees | 146 | 111,822 | 96,100 | 75,267 | 92,815 |
| Entity Type | Public | Public | Public | Public | Public |
Key Financial Charts
Sales Growth
Net Income Growth
Executives
| Name | Position | Board | Since | Age |
|---|---|---|---|---|
| Stephen Dilly, Ph.D. | Chairman | Executive Board | 2024 | 66 |
| Alison Moore, Ph.D | Director; President; Chief Executive Officer | Executive Board | 2025 | 59 |
| Georgia Erbez | Chief Business Officer; Chief Financial Officer | Senior Management | 2025 | 59 |
| Stefan Lutz, Ph.D | Chief Scientific Officer | Senior Management | 2025 | - |
| Karen Frechou-Armijo | Head - Human Resource; Senior Vice President | Senior Management | 2021 | - |
| Non Dignissim Eros | Proin vel | Convallis | 2026 | XY |
| Non Dignissim Eros | Proin vel | Convallis | 2026 | XY |
| Non Dignissim Eros | Proin vel | Convallis | 2026 | XY |
Still looking?
Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.
Explorer
Access more premium companies when you subscribe to Explorer